Urine-based Bladder Cancer Detection

About Qurin Diagnostics

Qurin Diagnostics is an early-stage biotech developing a novel platform to improve the accuracy and usability of liquid biopsy for early cancer detection. Its core innovation is a patented sample collection and biomarker pre-concentration technology designed to amplify cancer signals from biofluids like urine, addressing key limitations of current tests. Initially targeting bladder cancer, the company aims to build a pipeline of highly accurate, user-friendly diagnostic tests that facilitate earlier treatment and reduce healthcare costs. Qurin operates as a private, pre-revenue company within the vibrant Leiden Bio Science Park ecosystem.

Therapeutic Areas

Other Bladder Cancer Drugs